POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

In vitro Model for Cryptosporidium parvum Infection

ROLE OF APOPTOSIS IN EXPERIMENTAL CRYPTOSPORIDIUM PARVUM INFECTED ALBINO MICE

IN VITRO STUDY ON THE ANTIPARASITIC EFFECT OF OMEPRAZOLE ON CRYPTOSPORIDIUM PARVUM

DETECTION OF CRYPTOSPORIDIUM-INDUCED INTESTINAL TISSUE ALTERATIONS IN DEXAMETHASONE TREATED & UN-TREATED MICE

Study of Cryptosporidium infection in Liver Cirrhosis and animal model.

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALIN

IMMUNO-HISTOCHEMICAL CHANGES TRIGGERED BY REPEATED CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MICE

Transforming Growth Factor-β, Reverse IFN-γ Activation of Intestinal Epithelial Cells during Cryptosporidium parvum Infection

Control of the Waterborne Cryptosporidiosis: Evaluation of the Protective Role of Cryptosporidium parvum Oocysts Antigen in Infected Immunocompetent and Immunosuppressed Mice